NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 156 filers reported holding NEOGENOMICS INC in Q2 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $260,000 | +28.7% | 7,048 | +8.1% | 0.01% | +28.6% |
| Q2 2020 | $202,000 | +29.5% | 6,519 | -45.2% | 0.01% | +16.7% |
| Q2 2018 | $156,000 | -4.3% | 11,900 | -40.3% | 0.01% | 0.0% |
| Q1 2018 | $163,000 | -7.9% | 19,940 | -0.1% | 0.01% | -14.3% |
| Q4 2017 | $177,000 | -20.3% | 19,951 | 0.0% | 0.01% | -30.0% |
| Q3 2017 | $222,000 | +20.7% | 19,951 | -2.8% | 0.01% | +25.0% |
| Q2 2017 | $184,000 | +13.6% | 20,531 | -0.1% | 0.01% | 0.0% |
| Q1 2017 | $162,000 | -23.6% | 20,560 | -16.8% | 0.01% | -27.3% |
| Q4 2016 | $212,000 | +3.9% | 24,718 | -0.2% | 0.01% | 0.0% |
| Q3 2016 | $204,000 | -0.5% | 24,759 | -3.2% | 0.01% | 0.0% |
| Q2 2016 | $205,000 | -41.8% | 25,589 | -51.0% | 0.01% | -45.0% |
| Q1 2016 | $352,000 | -14.1% | 52,175 | +0.1% | 0.02% | -4.8% |
| Q4 2015 | $410,000 | – | 52,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |